WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

ORAL GLUCOSE TOLERANCE TESTS WITH A COMBINATION OF MOMORDICA CHARANTIA FRUITS AND TRIGONELLA FOENUM-GRAECUM SEEDS

Tridib Kumar Paul, Mahnaz Hossain Fariba, Md. Najmul Hossain, Mohammed Rahmatullah*

ABSTRACT

Background: The fruits of Momordica charantia L. and seeds of Trigonella foenum-graecum L. are considered traditionally in Bangladesh to lower elevated blood glucose levels in glucose-impaired persons. The fruits and seeds are also consumed in the cooked form as a vegetable and spice, respectively. It was of interest to evaluate the antihyperglycemic activity of a combination of methanolic extract of both fruits and seeds. Methods: Antihyperglycemic activity was determined through oral glucose tolerance test (OGTT) in mice. Results: Administration of methanol extract of Momordica charantia fruits (MEMC) and methanol extract of Trigonella foenum-graecum seeds (METF), separately at a dose of 400 mg per kg body weight each to glucose-loaded mice reduced blood glucose levels by 26.2 and 21.3%, respectively compared to control (untreated) mice. A combination of (MEMC + METF) at doses of 50, 100, 200 and 400 mg each extract reduced blood glucose levels, respectively by 24.9, 30.2, 34.9, and 40.5%. By comparison, a standard antihyperglycemic drug, glibenclamide, when administered at a dose of 10 mg per kg body weight, reduced blood glucose level by 41.9%. Conclusion: A combination of MEMC and METF (at 400 mg per kg each) can be effective in reducing blood glucose (that is improve oral glucose tolerance) nearly as efficiently as glibenclamide, and so can reduce dependency on this antidiabetic drug.

Keywords: Antihyperglycemic, Momordica charantia, Trigonella foenum-graecum, glibenclamide, OGTT.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More